TransMedics Group
NasdaqGM:TMDX
$ 131,41
$-3,36 (-2,49%)
131,41 $
$-3,36 (-2,49%)
Real-time: 03/10/2026 13:58

Quick Analysis

$1,01
Earnings Per Share
$13,12
Revenue Per Share
59,36%
Gross Margin %
$4,62 B
Market Cap
$0,51 B
Long-Term Debt
Earnings Per Share
$1,01
Revenue Per Share
$13,12
Gross Margin %
59,36%
Market Cap
$4,62 B
Long-Term Debt
$0,51 B

Financials

Year Year 2024 2023 2022 2021 2020 2019 2018
EPS Earnings Per Share $1,01 $0,07 $-1,23 $-1,60 $-1,16 $-2,36 $-5,00
Earnings Earnings $34,00M $2,29M $-39,61M $-44,74M $-31,75M $-50,08M $-24,45M
RPS Revenue Per Share $13,12 $7,38 $2,90 $1,08 $0,94 $1,11 $2,66
Revenue Revenue $441,54M $241,62M $93,46M $30,26M $25,64M $23,60M $13,02M
OCF Operating Cash Flow $48,80M $-13,03M $-45,82M $-28,86M $-30,27M $-32,29M $0,00M
FCF Free Cash Flow $-80,94M $-84,45M $-57,72M $-32,38M $-30,72M $-32,45M $0,00M
OM Operating Margin 8,49% 0,20% -33,64% -130,29% -102,91% -125,42% -155,47%
GM % Gross Margin % 59,36% 63,77% 69,84% 69,92% 64,88% 58,73% 44,05%
FCFS Free Cash Flow Per Share $-2,44 $-5,91 $-1,95 $-1,17 $-1,24 $-2,28 $-19,43
LT Debt Long-Term Debt $509,31M $506,20M $58,70M $35,20M $34,66M $34,15M $33,67M
Sha. Stocks 33,66M 32,72M 32,2M 27,96M 27,37M 21,22M 4,89M
×